talquetamab | ajai chari, md | ash 2022
Published 1 year ago • 1K plays • Length 9:33
Download video MP4
Download video MP3
Similar videos
-
7:07
asco/eha 2024 myeloma highlights | ajai chari, md | eha 2024
-
3:53
efficacy of reduced dosing of talquetamab in relapsed refractory myeloma | ajai chari, md | ash 2023
-
4:47
linker-mm1 study in rrmm | naresh bumma, md | ash 2022
-
5:22
individualized prediction model in myeloma & genome sequencing | francesco maura, md | ash 2022
-
2:10
new developments at ash | rafat abonour, md | ash 2022
-
23:03
how myeloma frontline therapy is changing - ajai chari, md | rt irvine, ca nov 5, 2022
-
17:55
talquetamab | therapies on the horizon #myeloma
-
56:40
immunotherapy 101 for multiple myeloma patients
-
4:16
what is the monoclonal antibody talvey™ (talquetamab)?
-
3:44
bispecific t cell engagers | noopur raje, md | ash 2022
-
2:57
modakafusp alfa (tak-573) | dan vogl, md, msce | ash 2022
-
6:18
talquetamab and teclistamab in rrmm: updated results from redirectt-1 | yael cohen, md | ims 2024
-
2:44
talquetamab use in treating relapsed refractory multiple myeloma | shebli atrash, md | ims 2024
-
7:55
managing the unique side effects of talquetamamb | ajai chari, md | eha 2024
-
5:29
updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
-
4:57
ash 2022: talquetamab showing promise in multiple myeloma clinical trial
-
2:00
advancements in immunotherapy agents | hearn j. cho, md | ash 2022
-
28:40
all about talvey (talquetamab)
-
10:34
talquetamab - guest lecture
-
6:31
real-world results from talquetamab and bispecific antibodies | carolina schinke, md | ash 2023
-
4:39
car-t bms-986354 | luciano costa, md, phd | ash 2022
Clip.africa.com - Privacy-policy